Evidence map›Paper›PMID 25228320›Full record

ReviewCirculation. Heart failure2014

Epigenetic mechanisms in heart failure pathogenesis.

Thomas G Di Salvo, Saptarsi M Haldar

Open access · bronzeAbstract readReview
In one paragraph

Review in Circulation. Heart failure, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy.Journal of molecular and cellular cardiology plus · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. BET Protein-Mediated Transcriptional Regulation in Heart Failure.International journal of molecular sciences · 2021
    Review
  10. Epigenetic therapies in heart failure.Journal of molecular and cellular cardiology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Epigenetic regulation in heart failure.Current opinion in cardiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Thomas G Di Salvo *Division of Cardiovascular Medicine, Vanderbilt Heart and Vascular Institute, Nashville TN.
Saptarsi M Haldar *Case Cardiovascular Research Institute, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland OH.
Case Western Reserve University · USUniversity School · US

Funding

KLF15 and Transcriptional Control of Muscle MetabolismR01DK093821 · NIDDK · J. DAVID GLADSTONE INSTITUTES · PI HALDAR, SAPTARSI · 2013 to 2017
$1.8M
NIDDK NIH HHS DK093821NIDDK NIH HHS R01 DK093821
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epigenesis, GeneticAnimalsChromatinDNAGenetic Predisposition to DiseaseHeart FailureHumansChromatinDNAchromatinetiologyheart failurehistoneshypertrophytranscription factors

Identifiers

PMID25228320
PMCPMC4169025
OpenAlexW2141184996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.